Osprey Polkadot Trust is a US-based company operating in industry. The company is headquartered in Tarrytown, New York. The company went IPO on 2022-05-03. Osprey Polkadot Trust (the Trust) is a statutory trust. The investment objective of the Trust is solely for the shares to realize long-term capital appreciation by tracking the price of DOT tokens, the native token to the Polkadot Network. The Trust is focused on developing a fully decentralized Web where users are in control. The Trust holds DOT and, from time to time, issues common shares of fractional undivided beneficial interest (Shares) in exchange for DOT. The shares are designed as a method for investors to gain investment exposure to DOT, similar to a direct investment in DOT. Osprey Funds, LLC is the sponsor and manager of the Trust and Delaware Trust Company serves as Trustee. Coinbase Custody Trust Company, LLC, is the custodian of the Trust. The transfer agent for the Trust (the Transfer Agent) is Continental Stock Transfer & Trust Company.
Cellyan Biotechnology Co Ltd 주요 수익원은 Power이며, 최신 수익 발표에서 수익은 197,125,807,000입니다. 지역별로는 Philippines이 Cellyan Biotechnology Co Ltd의 주요 시장이며, 수익은 250,956,365,000입니다.
Osprey Polkadot Trust은 수익성이 있나요?
no, 최신 재무제표에 따르면 Cellyan Biotechnology Co Ltd의 순손실은 $0입니다.